Home > Insider Trading > Filing (0001213900-25-060346)

Filing Details

Accession Number:: 0001213900-25-060346
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-07-01 16:00:11
Reporting Period:: 2025-04-28

Filing Date:: 2025-07-01
Accepted Time:: 2025-07-01 16:00:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1158780	Pluri Inc.	PLUR	Biological Products, (No Disgnostic Substances) (2836)	980351734

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1833124	Weinstein Alexandre Manieu	Apt 8002, Burgenstock Hotels &Amp; Resort, Burgenstock 30 Obburgen V8 6363		Yes	No	Yes	No
2055515	Ltd Holdings Chutzpah	4Th Floor, Liberation House Castle Street St Helier Y9 JE1 4HH		Yes	No	No	No

Transaction Summary

Purchased:	976,139 shares	Avg. Price: $4.61	Total Value: $4,500,000.79
Number of Shares After Transactions:	931,246 shares

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-04-28	523,437	$4.61	931,246	No	4	P	Indirect	Shares indirectly held through Chutzpah Holdings Limited
Common Stock	Acquisiton	2025-04-28	452,702	$4.61	452,702	No	4	P	Indirect	Shares indirectly held through Plantae Bioscience Ltd.
Common Stock	Disposition	2025-04-28	976,139	$0.00	931,246	No	4	J	Indirect	Shares indirectly held through Chutzpah Holdings Limited

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Shares indirectly held through Chutzpah Holdings Limited
No	4	P	Indirect	Shares indirectly held through Plantae Bioscience Ltd.
No	4	J	Indirect	Shares indirectly held through Chutzpah Holdings Limited

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Pre-Funded Warrants to purchase Common Shares	Acquisiton	2025-04-28	976,139	$0.00	976,139	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
976,139			No	4	J	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	10,250	Direct

Footnotes

This statement is jointly filed by and on behalf of each of Chutzpah Holdings Limited ("Chutzpah") and Mr. Weinstein. Mr. Weinstein indirectly owns 100% of Chutzpah and may be deemed to beneficially own securities owned by Chutzpah. Each reporting person (i) states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any securities covered by this statement; (ii) disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities; and (iii) declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.
Mr. Weinstein indirectly owns 77% of Plantae Bioscience Ltd. ("Plantae") and may be deemed to beneficially own securities owned by Plantae. Neither the filing of this statement nor anything herein shall be deemed an admission that Mr. Weinstein is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any securities owned by Plantae. Mr. Weinstein disclaims beneficial ownership of such securities covered by this statement, except to the extent of his pecuniary interest in such securities. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.
The Pre-Funded Warrants are exercisable at any time following the receipt of certain approvals from Pluri Inc.'s (the "Company") shareholders required by the applicable rules of the Nasdaq Capital Market, and remain exercisable until exercised in full.
On April 25, 2025, the Company entered into an amendment (the "Amendment") to its previously executed Securities Purchase Agreement, entered into on January 23, 2025 by the Company and Chutzpah. Pursuant to the Amendment, the Company and Chutzpah agreed to exchange 976,139 Common Shares for pre-funded warrants to purchase up to 976,139 Common Shares.